Pharmaceutical - Patents

Filter

Current filters:

Patents

Popular Filters

1 to 25 of 270 results

Indian government plans to establish dynamic and balanced IPR policy

Indian government plans to establish dynamic and balanced IPR policy

07-01-2015

Even as US President Barack Obama is slated to be the chief guest at India's Republic Day Parade on January…

IndiaPatentsPharmaceuticalPoliticsUSA

New guidance provides optimism for securing life sciences patents in USA

New guidance provides optimism for securing life sciences patents in USA

17-12-2014

The US Patent and Trademark Office (USPTO) has released its 2014 Interim Guidance on Patent Subject Matter…

PatentsPharmaceuticalPrometheus LabsUS Patent and Trademark OfficeUSA

Bayer fails in Indian Nexavar patent appeal

Bayer fails in Indian Nexavar patent appeal

13-12-2014

German pharma major Bayer suffered a significant disappointment on Friday, when India’s Supreme Court…

BayerIndiaLegalNatco PharmaNexavarOncologyPatentsPharmaceutical

Patent cliff means pharma will lose $65 billion by 2019, says report

Patent cliff means pharma will lose $65 billion by 2019, says report

11-12-2014

Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent…

AbilifyAstraZenecaEli LillyGlobalMarkets & MarketingNeurologicalOtsukaPatentsPharmaceuticalSeroquelZyprexa

Recently-announced timeline of UK Patent Box changes helps address uncertainty, says patent attorney

04-12-2014

Following UK Chancellor of the Exchequer George Osborne’s confirmation of an overhaul of the Patent…

FinancialPatentsPharmaceuticalResearchUK

Despite patent cliffs, pharma market shows signs of stability

19-11-2014

The pharmaceutical market is beginning to show signs of stability, with a review of 30 leading companies…

Biogen IdecBoehringer IngelheimFinancialJohnson & JohnsonPatentsPfizerPharmaceutical

UK Patent Box changes require urgent clarification, says Withers & Rogers

19-11-2014

Last month, Treasury Minister David Gauke gave a robust defence of the UK's Patent Box scheme, which…

FinancialPatentsPharmaceuticalPoliticsUK

UPDATE: UK agrees “Patent Box” compromise with Germany

UPDATE: UK agrees “Patent Box” compromise with Germany

13-11-2014

Germany and the UK have agreed a joint proposal to advance the negotiations on new rules for preferential…

FinancialGermanyPatentsPharmaceuticalPoliticsUK

India’s Cipla calls for revocation of Novartis’ Onbrez patents

01-11-2014

Indian drugmaker Cipla has asked the government to revoke five patents that Swiss pharma major Novartis…

CiplaIndiaMarkets & MarketingNovartisOnbrezPatentsPharmaceuticalRespiratory and PulmonaryUnibrez

Under US pressure, Indian government is getting its act together on IP matters

Under US pressure, Indian government is getting its act together on IP matters

27-10-2014

The pressure from the US government on India seems to be working. With India's intellectual property…

IndiaPatentsPharmaceuticalPoliticsPricing

Call for India’s Prime Minister to restore drug price caps

14-10-2014

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, with its affiliate country program,…

IndiaPatentsPharmaceuticalPoliticsPricing

BTG settles CroFab patent litigation with Bioclon and RDT

10-10-2014

UK specialist health care company BTG says it has settled its US patent infringement complaint against…

BTGCrofabInstituto BioclonLegalPatentsPharmaceuticalRare Disease TherapeuticsRare diseasesUSA

Bristol-Myers resolves Sustiva patent litigation in USA

Bristol-Myers resolves Sustiva patent litigation in USA

08-10-2014

US pharma major Bristol-Myers Squibb has successfully resolved all outstanding US patent litigation relating…

Anti-viralsAtriplaBristol-Myers SquibbCiplaLegalMerck & CoPatentsPharmaceuticalSustivaUSA

Legal change to reduce patent infringements could attract drug research back to the UK

Legal change to reduce patent infringements could attract drug research back to the UK

01-10-2014

A legal amendment which takes effect today could help to attract drug research back to the UK, according…

LegalPatentsPharmaceuticalUKUnited Kingdom

EXPERT VIEW: Utilizing supplementary protection certificates for active ingredients in the pharma industry

EXPERT VIEW: Utilizing supplementary protection certificates for active ingredients in the pharma industry

29-09-2014

Intellectual Property can be vital for the success of any pharmaceutical invention. It is very important…

EuropeInterviewsLegalPatentsPharmaceuticalUnited Kingdom

Despite limited size, Chile's pharma market offers growing opportunity

23-09-2014

By the end of 2014, the Chilean pharmaceutical market is expected to be worth $2 billion, increasing…

ChileHealthcareMarkets & MarketingPatentsPharmaceuticalRegulation

USIBC concludes successful pharmaceutical mission to India

USIBC concludes successful pharmaceutical mission to India

28-08-2014

The US-India Business Council (USIBC) has concluded its Pharmaceutical Executive Mission to Delhi, India.…

IndiaPatentsPharmaceuticalPricingUSA

Depomed prevails in Gralise ANDA litigation with Actavis

Depomed prevails in Gralise ANDA litigation with Actavis

20-08-2014

US drug maker Depomed saw its shares climb more than 12% to $14.76 on Tuesday, on the news that the firm…

ActavisDepomedGraliseLegalNeurologicalPatentsPharmaceuticalUSA

Indian Health Ministry seeking compulsory license for B-MS’ Sprycel

Indian Health Ministry seeking compulsory license for B-MS’ Sprycel

19-08-2014

Anti-leukemia drug dasatinib, made by US pharma major Bristol-Myers Squibb and sold in India under the…

Bristol-Myers SquibbDasatinibIndiaOncologyPatentsPharmaceuticalSprycel

Teva to sue Dr Reddy’s over Copaxone patent infringement

Teva to sue Dr Reddy’s over Copaxone patent infringement

08-08-2014

Global generics leader Teva Pharmaceutical Industries yesterday confirmed that it has received the first…

CopaxoneDr Reddy's LaboratoriesLegalNeurologicalPatentsPharmaceuticalTeva Pharmaceutical IndustriesUSA

Report: Why pharmaceutical prices drop once drugs are off-patent

Report: Why pharmaceutical prices drop once drugs are off-patent

07-07-2014

The USA-based Pacific Research Institute has released a new report, titled The Economics of Pharmaceutical…

GlobalPatentsPharmaceuticalPricing

Teva files citizen petition with FDA regarding Copaxone complexity

Teva files citizen petition with FDA regarding Copaxone complexity

03-07-2014

Teva Pharmaceutical Industries says it has filed a citizen petition regarding the approvability of purported…

CopaxoneLegalNeurologicalPatentsPharmaceuticalRegulationTeva Pharmaceutical IndustriesUSA

Rilutek patent expiry to cause negative growth in ALS treatment market by 2018

Rilutek patent expiry to cause negative growth in ALS treatment market by 2018

25-06-2014

The amyotrophic lateral sclerosis (ALS) treatment market value will decline from $64 million in 2013…

EuropeJapanMarkets & MarketingNeurologicalPatentsPharmaceuticalRilutekSanofiUSA

1 to 25 of 270 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top